Flagship Ventures Opportunities Fund I General Partner LLC's Net Worth
$0
Who is Flagship Ventures Opportunities Fund I General Partner LLC?
Flagship Ventures Opportunities Fund I General Partner LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kaleido Biosciences, Inc., Foghorn Therapeutics Inc., Evelo Biosciences, Inc., Rubius Therapeutics, Inc., and Axcella Health Inc..
SEC CIK
Flagship Ventures Opportunities Fund I General Partner LLC's CIK is 0001725004
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.14% | 215K |
$11.50 | $2,472,500.00 | 5.41M |
Feb 8
| |||
Form 4
| +62.67% | 2M |
$7.50 | $15,000,000.00 | 5.19M |
Jun 4
| |||
Form 4
| +47.12% | 12M |
$15.00 | $13,999,995.00 | 37.48M |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foghorn Therapeutics Inc. (FHTX) Snapshot price: $7.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.67M |
$16.00 |
—
| 12.67M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axcella Health Inc. (AXLA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +79.47% | 10.38M |
$1.64 | $17,029,366.40 | 23.45M |
Oct 13
| |||
Form 4
| +72.21% | 6.32M |
$1.91 | $12,069,998.61 | 15.07M |
Mar 16
| |||
Form 4
| +76.74% | 3.8M |
$4.75 | $18,050,000.00 | 8.75M |
May 18
| |||
Form 4
| +46.30% | 6.03M |
$20.00 |
—
| 19.07M |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +288.55% | 27.4M |
$1.46 | $39,999,998.14 | 36.89M |
May 27
| |||
Form 4
| +1.39% | 130K |
$15.00 | $1,950,000.00 | 9.49M |
Feb 2
| |||
Form 4
| +99.33% | 4.67M |
$3.75 | $17,499,997.50 | 9.36M |
Jun 29
| |||
Form 4
| +447.55% | 14.9M |
$16.00 | $4,500,000.00 | 18.23M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.057
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.89% | 210K |
$29.00 | $6,090,000.00 | 23.89M |
Mar 19
| |||
| No matching records found | |||||||||